ADAMTS13 expression in human chondrosarcoma cells induced by insulin

Year 2014, , 226 - 232, 01.06.2014

Rıdvan Fırat Sümeyya Akyol Fatih Sabri Kurşunlu Veli Uğurcu Gönül Erden Özlem Çakmak Kadir Demircan

https://doi.org/10.5799/ahinjs.01.2014.02.0393

Cited By: 2

Abstract

Objectives: A Disintegrin-like Metalloproteinase with Thrombospondin Motifs (ADAMTS) proteins is a proteinase enzyme group that primarily located in the extracellular matrix (ECM). Insulin has been known to stimulate proteoglycan biosynthesis in chondrosarcoma chondrocytes and thereby the levels of ADAMTS proteins. The aim of this study is to evaluate the time-dependent effects of insulin on the ADAMTS13 expression in OUMS-27 human chondrosarcoma cell line to test the hypothesis that insulin diminishes ADAMTS13 expression because of its anabolic effects. Methods: To test this hypothesis OUMS-27 cells were cultured in Dulbecco\'s modified Eagle\' medium (DMEM) containing 10μg/mL insulin. The medium containing insulin was changed every other day up to 11th day. Cells were harvested at 1, 3, 7, and 11th days and protein and RNA isolations were performed at the proper times. The levels of RNA expression of ADAMTS13 was quantified by qRT-PCR using appropriate primers while protein levels was detected by Western blot technique using anti-ADAMTS13 antibody. Results: Although there was a decrease in both RNA and protein levels in insulin-applied groups compared to the control cells, it was not statistically significant. Conclusion: Under the light of our findings, it is suggested that insulin does not participate in regulation of ADAMTS13 in OUMS-27 chondrosarcoma cells. J Clin Exp Invest 2014; 5 (2): 226-232

Keywords

Insulin; ADAMTS13, chondrosarcoma, OUMS-27, RNA

Insulin tarafindan indüklenmiş insan kondrosarkom hücrelerinde ADAMTS13 ekspresyonu

Abstract

Amaç: A Disintegrin-like Metalloproteinase with Thrombospondin Motifs (ADAMTS) proteinleri esas olarak ekstraselüler matrikste (ECM) bulunan bir ptoteinaz enzim grubudur. İnsülinin kondrosarkom kondrositlerinde proteoglikan sentezini stimüle ettiği uzun yıllardır bilinmekteydi. Dolayısıyla bu çalışmanın amacı insülinin, OUMS-27 insan kondrosarkom hücre kültüründeki zaman bağımlı etkilerini değerlendirmek ve insülinin anabolik etkilerinden dolayı ADAMTS13 ekspresyonunu azaltma ihtimali hipotezini test etmektir. Yöntemler: Bu hipotezi test etmek için OUMS-27 hücrelerinin, 10μg/mL insulin içeren Dulbecco\'s modified Eagle besiyerinde (DMEM) kültürü yapıldı. 11. güne kadar iki günde bir besiyeri ile birlikte insülin takviyesi yapıldı. Hücreler 1, 3, 7 ve 11. günlerde harvest edilerek uygun zamanlarda protein ve RNA izolasyonu yapıldı. ADAMTS13 RNA ekspresyonu uygun primerler kullanılarak qRT-PCR yöntemi ile ölçüldü ve anti-ADAMTS13 antikorları kullanılarak Western blot yöntemi ile protein miktarı ölçüldü. Bulgular: Kontrol grubu ile karşılaştırıldığında insülin uygulanan hücre gruplarında, hem RNA hem de protein miktarı azaldı ancak bu istatistiksel olarak anlamlı değildi. Sonuç: Bu bulgular ışığında insülinin OUMS-27 kondrosarkom hücrelerinde ADAMTS13 regülasyonuna pozitif ya da negative herhangi bir etki yapmadığı sonucu ortaya çıkmıştır.

Keywords

İnsulin, ADAMTS13, Kondrosarkom, OUMS-27, RNA

References

• Gelderblom H, Hogendoorn PC, Dijkstra SD, et al. The clinical approach towards chondrosarcoma. Oncolo- gist 2008;13:320-329.
• Kumar S, Rao N, Ge R. Emerging Roles of AD- AMTSs in Angiogenesis and Cancer. Cancers (Basel) 2012;4:1252-1299.
• Niiya M, Uemura M, Zheng XW, et al. Increased AD- AMTS-13 proteolytic activity in rat hepatic stellate cells upon activation in vitro and in vivo. J Thromb Haemost 2006;4:1063-1070.
• Uemura M, Tatsumi K, Matsumoto M, et al. Localiza- tion of ADAMTS13 to the stellate cells of human liver. Blood 2005;106:922-924.
• Zhou W, Inada M, Lee TP, et al. ADAMTS13 is expressed in hepatic stellate cells. Lab Invest 2005;85:780-788.
• Shang D, Zheng XW, Niiya M, Zheng XL. Apical sorting of ADAMTS13 in vascular endothelial cells and Ma- din-Darby canine kidney cells depends on the CUB domains and their association with lipid rafts. Blood 2006;108:2207-2215.
• Turner N, Nolasco L, Tao Z, et al. Human endothelial cells synthesize and release ADAMTS-13. J Thromb Haemost 2006;4:1396-1404.
• Levy GG, Nichols WC, Lian EC, et al. Mutations in a member of the ADAMTS gene family cause thrombot- ic thrombocytopenic purpura. Nature 2001;413:488- 494.
• Lee M, Rodansky ES, Smith JK, Rodgers GM. ADAMTS13 promotes angiogenesis and modu- lates VEGF-induced angiogenesis. Microvasc Res 2012;84:109-115.
• Koo BH, Oh D, Chung SY, et al. Deficiency of von Wil- lebrand factor-cleaving protease activity in the plasma of malignant patients. Thromb Res 2002;105:471-476.
• Lombardi AM, Fabris R, Berti de Marinis G, et al. De- fective ADAMTS13 synthesis as a possible conse- quence of NASH in an obese patient with recurrent thrombotic thrombocytopenic purpura. Eur J Haema- tol 2014;92:497-501.
• Taniguchi S, Hashiguchi T, Ono T, et al. Association between reduced ADAMTS13 and diabetic nephropa- thy. Thromb Res 2010;125:e310-316.
• Hugenholtz GC, Adelmeijer J, Meijers JC, et al. An unbalance between von Willebrand factor and AD- AMTS13 in acute liver failure: implications for hemo- stasis and clinical outcome. Hepatology 2013;58:752- 761.
• Andersson HM, Siegerink B, Luken BM, et al. High VWF, low ADAMTS13, and oral contraceptives in- crease the risk of ischemic stroke and myocardial in- farction in young women. Blood 2012;119:1555-1560.
• Kaikita K, Soejima K, Matsukawa M, et al. Reduced von Willebrand factor-cleaving protease (ADAMTS13) activity in acute myocardial infarction. J Thromb Hae- most 2006;4:2490-2493.
• Matsukawa M, Kaikita K, Soejima K, et al. Serial changes in von Willebrand factor-cleaving protease (ADAMTS13) and prognosis after acute myocardial infarction. Am J Cardiol 2007;100:758-763.
• Fujioka M, Nakano T, Hayakawa K, et al. ADAMTS13 gene deletion enhances plasma high-mobility group box1 elevation and neuroinflammation in brain isch- emia-reperfusion injury. Neurol Sci 2012;33:1107- 1115.
• Zhao BQ, Chauhan AK, Canault M, et al. von Wil- lebrand factor-cleaving protease ADAMTS13 reduces ischemic brain injury in experimental stroke. Blood 2009;114:3329-3334.
• Bongers TN, de Maat MP, van Goor ML, et al. High von Willebrand factor levels increase the risk of first ischemic stroke: influence of ADAMTS13, inflamma- tion, and genetic variability. Stroke 2006;37:2672- 2677.
• Stepanian A, Cohen-Moatti M, Sanglier T, et al. Von Willebrand factor and ADAMTS13: a candidate cou- ple for preeclampsia pathophysiology. Arterioscler Thromb Vasc Biol 2011;31:1703-1709.
• Burtis CA, Ashwood ER, Bruns DE. Tietz Textbook of Clinical Chemistry and Molecular Diagnostics, 4th Edition. Philadelphia: Elsevier Sounders, 2006:485- 523.
• Rhodes CJ, White MF. Molecular insights into insulin action and secretion. Eur J Clin Invest 2002; 32 Suppl 3:3-13.
• Saltiel AR, Kahn CR. Insulin signalling and the regulation of glucose and lipid metabolism. Nature 2001;414:799-806.
• Foley TP, Jr, Nissley SP, Stevens RL, et al. Demon- stration of receptors for insulin and insulin-like growth factors on Swarm rat chondrosarcoma chondro- cytes. Evidence that insulin stimulates proteoglycan synthesis through the insulin receptor. J Biol Chem 1982;257:663-669.
• Stevens RL, Nissley SP, Kimura JH, et al. Effects of in- sulin and multiplication-stimulating activity on proteo- glycan biosynthesis in chondrocytes from the Swarm rat chondrosarcoma. J Biol Chem 1981;256:2045- 2052.
• Demircan K, Hirohata S, Nishida K, et al. ADAMTS-9 is synergistically induced by interleukin-1beta and tu- mor necrosis factor alpha in OUMS-27 chondrosarco- ma cells and in human chondrocytes. Arthritis Rheum 2005;52:1451-1460.
• Fujimura Y, Matsumoto M, Yagi H, et al. Von Will- ebrand factor-cleaving protease and Upshaw-Schul- man syndrome. Int J Hematol 2002;75:25-34.
• Zheng XL. Structure-function and regulation of AD- AMTS-13 protease. J Thromb Haemost 2013;11Suppl 1:11-23.
• Muroi C, Fujioka M, Mishima K, et al. Effect of AD- AMTS-13 on cerebrovascular microthrombosis and neuronal injury after experimental subarachnoid hem- orrhage. J Thromb Haemost 2014;12:505-514.
• Tauchi R, Imagama S, Ohgomori T, et al. ADAMTS-13 is produced by glial cells and upregulated after spinal cord injury. Neurosci Lett 2012;517:1-6.
• Jamale TE, Hase NK, Kulkarni M, et al. Hereditary ADAMTS 13 deficiency presenting as recurrent acute kidney injury. Indian J Nephrol 2012;22:298-300.
• Bramham K, Hilton R, Horsfield C, et al. ADAMTS-13 deficiency: can it cause chronic renal failure? Nephrol Dial Transplant 2011;26:742-744.
• Sane DC, Owen J. Link between ADAMTS-13 and troponin levels? Crit Care Med 2008; 36: 2959-2960; author reply 2960-2951.
• Martin K, Borgel D, Lerolle N, et al. Decreased AD- AMTS-13 (A disintegrin-like and metalloprotease with thrombospondin type 1 repeats) is associated with a poor prognosis in sepsis-induced organ failure. Crit Care Med 2007;35:2375-2382.